genetic screening

Oncology

Functional cancer profiling is an important step forward in the progress of oncology treatment, with the potential to transform patient outcomes.

News

Patients in the EU with the ultra-rare disease WHIM syndrome now have their first approved treatment, Norgine's Xolremdi.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.